Entity Common Stock, Shares Outstanding of Bionik Laboratories Corp. from 30 Sep 2011 to 16 Jun 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Bionik Laboratories Corp. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 30 Sep 2011 to 16 Jun 2023.
  • Bionik Laboratories Corp. Entity Common Stock, Shares Outstanding for the quarter ending 16 Jun 2023 was 12,480,431, a 84% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Bionik Laboratories Corp. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2023 12,480,431 +5,713,317 +84% 16 Jun 2023 10-K 21 Jun 2023 2023 FY
Q4 2022 6,878,162 +1,087,242 +19% 03 Feb 2023 10-Q 08 Feb 2023 2023 Q3
Q3 2022 6,768,162 +977,242 +17% 07 Nov 2022 10-Q 09 Nov 2022 2023 Q2
Q2 2022 6,767,114 +1,177,739 +21% 06 Jun 2022 10-K 09 Jun 2022 2022 FY
Q4 2021 5,790,920 +785,936 +16% 07 Feb 2022 10-Q 09 Feb 2022 2022 Q3
Q3 2021 5,790,920 +781,769 +16% 08 Nov 2021 10-Q 10 Nov 2021 2022 Q2
Q2 2021 5,589,375 +580,224 +12% 18 Jun 2021 10-K 24 Jun 2021 2021 FY
Q4 2020 5,004,984 +14,243 +0.28% 10 Feb 2021 10-Q 11 Feb 2021 2020 Q3
Q3 2020 5,009,151 +38,556 +0.78% 12 Nov 2020 10-Q 12 Nov 2020 2020 Q2
Q2 2020 5,009,151 +1,306,753 +35% 25 Jun 2020 10-K 29 Jun 2020 2020 FY
Q4 2019 4,990,741 +2,649,281 +113% 03 Feb 2020 10-Q 14 Feb 2020 2019 Q3
Q3 2019 4,970,595 +2,632,631 +113% 12 Nov 2019 10-Q 14 Nov 2019 2019 Q2
Q2 2019 3,702,398 -244,171,484 -99% 27 Jun 2019 10-K 01 Jul 2019 2019 FY
Q4 2018 2,341,460 -53,543,819 -96% 08 Feb 2019 10-Q 11 Feb 2019 2019 Q3
Q3 2018 2,337,964 -53,547,315 -96% 13 Nov 2018 10-Q 13 Nov 2018 2019 Q2
Q2 2018 247,873,882 +198,988,775 +407% 25 Jun 2018 10-K 27 Jun 2018 2018 FY
Q4 2017 55,885,279 +8,642,570 +18% 13 Feb 2018 10-Q 13 Feb 2018 2018 Q3
Q3 2017 55,885,279 +9,522,738 +21% 13 Nov 2017 10-Q 13 Nov 2017 2018 Q2
Q2 2017 48,885,107 +26,172,566 +115% 25 Jun 2017 10-K 29 Jun 2017 2017 FY
Q4 2016 47,242,709 14 Feb 2017 10-Q 14 Feb 2017 2017 Q3
Q3 2016 46,362,541 +23,934,228 +107% 10 Nov 2016 10-Q 14 Nov 2016 2017 Q2
Q2 2016 22,712,541 +3,758,041 +20% 22 Jun 2016 10-KT 30 Jun 2016 2016 FY
Q1 2016 22,591,292 -43,248,208 -66% 11 Mar 2016 10-K 18 Mar 2016 2015 FY
Q3 2015 22,428,313 -93,790,070 -81% 10 Nov 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 18,954,500 -97,263,883 -84% 20 May 2015 10-Q 17 Mar 2016 2015 Q1
Q1 2015 65,839,500 -50,378,883 -43% 15 Apr 2015 10-K 15 Apr 2015 2014 FY
Q3 2014 116,218,383 0 0% 14 Nov 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 116,218,383 0 0% 13 Aug 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 116,218,383 +111,109,883 +2175% 14 Apr 2014 10-K 15 Apr 2014 2013 FY
Q3 2013 116,218,383 30 Sep 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 116,218,383 14 Aug 2013 10-Q 14 Aug 2013 2013 Q2
Q1 2013 5,108,500 +5,108,499 06 Mar 2013 10-K 06 Mar 2013 2012 FY
Q4 2012 4,988,600 +100 +0% 19 Nov 2012 10-Q 19 Nov 2012 2012 Q3
Q1 2012 1* 08 May 2012 10-Q 15 May 2012 2012 Q1
Q4 2011 4,988,500 31 Dec 2011 10-K 11 Apr 2012 2011 FY
Q3 2011 4,900,000 30 Sep 2011 10-Q 21 Nov 2011 2011 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.